Artículos con órdenes de acceso público - James M StoneMás información
No disponibles en ningún lugar: 5
The blood–brain barrier in psychosis
TA Pollak, S Drndarski, JM Stone, AS David, P McGuire, NJ Abbott
The Lancet Psychiatry 5 (1), 79-92, 2018
Órdenes: UK Medical Research Council, National Institute for Health Research, UK …
Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy—a [123I]CNS-1261 SPET study
JM Stone, K Erlandsson, E Arstad, L Squassante, V Teneggi, RA Bressan, ...
Psychopharmacology 197, 401-408, 2008
Órdenes: US National Institutes of Health
Phenomenologically distinct psychotomimetic effects of ketamine are associated with cerebral blood flow changes in functionally relevant cerebral foci: a continuous arterial …
TA Pollak, S De Simoni, B Barimani, FO Zelaya, JM Stone, MA Mehta
Psychopharmacology 232 (24), 4515-4524, 2015
Órdenes: US National Institutes of Health, US Department of Veterans Affairs, UK …
An initial investigation of abnormal bodily phenomena in subjects at ultra high risk for psychosis: Their prevalence and clinical implications
L Madeira, I Bonoldi, M Rocchetti, C Samson, M Azis, B Queen, ...
Comprehensive Psychiatry 66, 39-45, 2016
Órdenes: UK Medical Research Council, Wellcome Trust
Exploring the mechanisms of action of probiotics in depression: Results from a randomized controlled pilot trial
VL Nikolova, AJ Cleare, AH Young, JM Stone
Journal of Affective Disorders, 2025
Órdenes: National Institute for Health Research, UK
Disponibles en algún lugar: 88
Glutamate and dopamine in schizophrenia: An update for the 21st century
O Howes, R McCutcheon, J Stone
Journal of psychopharmacology 29 (2), 97-115, 2015
Órdenes: UK Medical Research Council, National Institute for Health Research, UK
Perturbations in gut microbiota composition in psychiatric disorders: a review and meta-analysis
VL Nikolova, MRB Smith, LJ Hall, AJ Cleare, JM Stone, AH Young
JAMA psychiatry 78 (12), 1343-1354, 2021
Órdenes: UK Biotechnology and Biological Sciences Research Council, UK Medical …
Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function
A Demjaha, A Egerton, RM Murray, S Kapur, OD Howes, JM Stone, ...
Biological psychiatry 75 (5), e11-e13, 2014
Órdenes: UK Medical Research Council
Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology
JM Stone, C Dietrich, R Edden, MA Mehta, S De Simoni, LJ Reed, ...
Molecular psychiatry 17 (7), 664-665, 2012
Órdenes: US National Institutes of Health
Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis
RL Carhart-Harris, R Leech, D Erritzoe, TM Williams, JM Stone, J Evans, ...
Schizophrenia bulletin 39 (6), 1343-1351, 2013
Órdenes: UK Medical Research Council
Evidence-based guidelines for the pharmacological treatment of schizophrenia: updated recommendations from the British Association for Psychopharmacology
TRE Barnes, R Drake, C Paton, SJ Cooper, B Deakin, IN Ferrier, ...
Journal of Psychopharmacology 34 (1), 3-78, 2020
Órdenes: UK Medical Research Council, National Institute for Health Research, UK
Treatment-resistant schizophrenia patients show elevated anterior cingulate cortex glutamate compared to treatment-responsive
E Mouchlianitis, MAP Bloomfield, V Law, K Beck, S Selvaraj, N Rasquinha, ...
Schizophrenia bulletin 42 (3), 744-752, 2016
Órdenes: UK Medical Research Council, National Institute for Health Research, UK
Ketamine: a tale of two enantiomers
LA Jelen, AH Young, JM Stone
Journal of Psychopharmacology 35 (2), 109-123, 2021
Órdenes: UK Medical Research Council, National Institute for Health Research, UK …
Drug models of schizophrenia
H Steeds, RL Carhart-Harris, JM Stone
Therapeutic advances in psychopharmacology 5 (1), 43-58, 2015
Órdenes: National Institute for Health Research, UK
Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study
S Jauhar, M Veronese, MM Nour, M Rogdaki, P Hathway, FE Turkheimer, ...
Molecular psychiatry 24 (10), 1502-1512, 2019
Órdenes: UK Medical Research Council, National Institute for Health Research, UK …
Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE)
A Egerton, BV Broberg, N Van Haren, K Merritt, GJ Barker, DJ Lythgoe, ...
Molecular psychiatry 23 (11), 2145-2155, 2018
Órdenes: National Institute for Health Research, UK
The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study
S Jauhar, R McCutcheon, F Borgan, M Veronese, M Nour, F Pepper, ...
The Lancet Psychiatry 5 (10), 816-823, 2018
Órdenes: UK Medical Research Council, National Institute for Health Research, UK …
Cannabis use and transition to psychosis in people at ultra-high risk
LR Valmaggia, FL Day, C Jones, S Bissoli, C Pugh, D Hall, ...
Psychological Medicine 44 (12), 2503-2512, 2014
Órdenes: UK Medical Research Council, National Institute for Health Research, UK
Long-term heavy ketamine use is associated with spatial memory impairment and altered hippocampal activation
CJA Morgan, CM Dodds, H Furby, F Pepper, J Fam, TP Freeman, ...
Frontiers in psychiatry 5, 149, 2014
Órdenes: UK Medical Research Council
Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis
A Egerton, JM Stone, CA Chaddock, GJ Barker, I Bonoldi, RM Howard, ...
Neuropsychopharmacology 39 (12), 2891-2899, 2014
Órdenes: UK Medical Research Council, National Institute for Health Research, UK
La información de publicación y financiación se determina de forma automática mediante un programa informático